Twitter | Search | |
Search Refresh
INSTITUT PASTEUR 18 Oct 16
Reply Retweet Like
Shaz still shielding Shazza 🎵 Nov 13
Nails done 💅🏼 for tomorrow, such a relief to have nails when I was having some of my actual nails fell off, yet still some call me shallow for painting my nails, oh well like I give a shit x 😂🤣
Reply Retweet Like
Oncology Times Aug 8
A New Approach to Spur the Immune System to Attack Lymphoma via
Reply Retweet Like
HemOnc Today 1 Nov 14
prophylaxis with single-agent effective after allogeneic transplant
Reply Retweet Like
Shaz still shielding Shazza 🎵 13 Feb 17
Yes as you know my is ongoing one of the 3,567 side effects is nails breaking, with 3 fell off 😱man that hurt x 😭
Reply Retweet Like
Stefano Cattaneo DVM 15 Jan 14
low-dose seems to be a well-tolerated option for cats bearing primary or metastatic tumours
Reply Retweet Like
Shaz still shielding Shazza 🎵 18 Mar 16
Replying to @RonThornton
so do I! Loads of side effects obviously, but far less than which was pure EVIL! X 😱
Reply Retweet Like
Shaz still shielding Shazza 🎵 5 Feb 17
I worked that out 4 yrs ago when diagnosed they gave me the cheapest most horrendous it was worse than the cancer x
Reply Retweet Like
Dr Ai Lyn Tan Mar 27
Reply Retweet Like
The Lancet Oncology Sep 25
Online First: phase 3 randomised trial of and continuous low-dose as maintenance in patients with high-risk rhabdomyosarcoma—the RMS 2005 study
Reply Retweet Like
KIReports 29 Jan 19
Reply Retweet Like
Neil Raden 1 Jun 19
The drug is a medicalized form of a chemical weapon from WWI invented by Bayer, Mustard gas. Welcome to chemotherapy.
Reply Retweet Like
Healio Rheumatology 23 Mar 16
Response to may have link for patients with :
Reply Retweet Like
Jyoti Baharani “wash your hands & mask up” 30 May 14
therapy in idiopathic nephropathy gives a threefold increase in cancer risk.
Reply Retweet Like
Rare Diseases 14 Nov 16
. Recommandation for ® in Combination with and for Relapsed CLL
Reply Retweet Like
The Lancet Oncology Nov 18
ICYMI: Time-to- after front-line , , and for : a retrospective, multicohort study
Reply Retweet Like
ACS Journal Cancer 7 Mar 17
Cardiomyopathy after post-HCT may be caused by infectious complications & assoc w/ worse survival
Reply Retweet Like
Medicastra 11 Oct 17
Replying to @RheumatologyUK
Liking the emphatic yes to the question whether can be used in critical cases of above after 12 weeks. Great info.
Reply Retweet Like
Amit Patel🇬🇧 Sep 28
Post on days +3 and +5 is associated with low rates of severe acute and chronic post donor stem cell transplant using conditioning in an Italian cohort @British_SocBMT
Reply Retweet Like
The Lancet Oncology Mar 12
Online first: phase 2 trial of , , , & plus high-dose plus for newly diagnosed intravascular large B-cell —the PRIMEUR-IVL study
Reply Retweet Like